Published in Chest on January 01, 2005
The SF-36 and SGRQ: validity and first look at minimum important differences in IPF. Respir Med (2009) 2.18
The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis. Respir Med (2012) 1.04
Dyspnea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease. Chest (2010) 1.04
Impact of a disease-management program on symptom burden and health-related quality of life in patients with idiopathic pulmonary fibrosis and their care partners. Heart Lung (2009) 0.98
Development of the ATAQ-IPF: a tool to assess quality of life in IPF. Health Qual Life Outcomes (2010) 0.98
Patient-reported outcomes in idiopathic pulmonary fibrosis research. Chest (2012) 0.88
The psychometric properties of the St George's Respiratory Questionnaire (SGRQ) in patients with idiopathic pulmonary fibrosis: a literature review. Health Qual Life Outcomes (2014) 0.87
Perceptions, experiences and needs of patients with idiopathic pulmonary fibrosis. J Adv Nurs (2014) 0.83
Clinical and economic burden of idiopathic pulmonary fibrosis: a retrospective cohort study. BMC Pulm Med (2016) 0.82
Health-related quality of life and 6 min walk distance in patients with idiopathic pulmonary fibrosis. Can Respir J (2011) 0.80
Benefits of pulmonary rehabilitation in idiopathic pulmonary fibrosis. Respir Care (2011) 0.80
The construct validity of the health utilities index mark 3 in assessing health status in lung transplantation. Health Qual Life Outcomes (2010) 0.79
Assessing exertional dyspnea in patients with idiopathic pulmonary fibrosis. Respir Med (2013) 0.78
Mindfulness-based stress reduction in patients with interstitial lung diseases: a pilot, single-centre observational study on safety and efficacy. BMJ Open Respir Res (2015) 0.76
Combined pulmonary fibrosis and emphysema: effect of pulmonary rehabilitation in comparison with chronic obstructive pulmonary disease. BMJ Open Respir Res (2016) 0.75
Protocol for a mixed-methods study of supplemental oxygen in pulmonary fibrosis. BMC Pulm Med (2014) 0.75
Outcome Measures for Clinical Trials in Interstitial Lung Diseases. Curr Respir Med Rev (2016) 0.75
Preventing complications of central venous catheterization. N Engl J Med (2003) 16.18
Benefits and harms of CT screening for lung cancer: a systematic review. JAMA (2012) 8.71
An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med (2006) 5.29
Translating the Diabetes Prevention Program lifestyle intervention for weight loss into primary care: a randomized trial. JAMA Intern Med (2013) 3.69
Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest (2007) 3.36
Lung cancer incidence in never smokers. J Clin Oncol (2007) 3.20
Outcomes in critically ill patients before and after the implementation of an evidence-based nutritional management protocol. Chest (2004) 2.89
A randomized clinical trial of peak flow versus symptom monitoring in older adults with asthma. Am J Respir Crit Care Med (2006) 2.88
Catheter-directed therapy for the treatment of massive pulmonary embolism: systematic review and meta-analysis of modern techniques. J Vasc Interv Radiol (2009) 2.79
Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 2.72
Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data. Perm J (2012) 2.55
The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules. Chest (2014) 2.30
Comparison of dynamic block randomization and minimization in randomized trials: a simulation study. Clin Trials (2011) 2.22
Impact of the lung allocation score on lung transplantation for pulmonary arterial hypertension. Am J Respir Crit Care Med (2009) 2.19
Lung cancer screening. Am J Respir Crit Care Med (2015) 2.14
Decision making in patients with pulmonary nodules. Am J Respir Crit Care Med (2011) 2.05
Systematic review: safety and efficacy of extended-duration antiviral chemoprophylaxis against pandemic and seasonal influenza. Ann Intern Med (2009) 1.99
Clinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis: a systematic review. Arch Neurol (2006) 1.92
What do you mean, a spot?: A qualitative analysis of patients' reactions to discussions with their physicians about pulmonary nodules. Chest (2013) 1.79
Associations between physical activity and 30-day readmission risk in chronic obstructive pulmonary disease. Ann Am Thorac Soc (2014) 1.74
Asthma in the elderly: Current understanding and future research needs--a report of a National Institute on Aging (NIA) workshop. J Allergy Clin Immunol (2011) 1.69
Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives. Health Qual Life Outcomes (2005) 1.69
Screening and prevention of venous thromboembolism in critically ill patients: a decision analysis and economic evaluation. Am J Respir Crit Care Med (2011) 1.58
Behavioral weight loss and physical activity intervention in obese adults with asthma. A randomized trial. Ann Am Thorac Soc (2015) 1.58
Positron emission tomography 18F-fluorodeoxyglucose uptake and prognosis in patients with surgically treated, stage I non-small cell lung cancer: a systematic review. J Thorac Oncol (2009) 1.57
Variability in antibiotic prescribing patterns and outcomes in patients with clinically suspected ventilator-associated pneumonia. Chest (2003) 1.56
Automated identification of patients with pulmonary nodules in an integrated health system using administrative health plan data, radiology reports, and natural language processing. J Thorac Oncol (2012) 1.54
When the average applies to no one: personalized decision making about potential benefits of lung cancer screening. Ann Intern Med (2012) 1.51
Cost and outcomes of patients with solitary pulmonary nodules managed with PET scans. Chest (2009) 1.51
Asthma control, severity, and quality of life: quantifying the effect of uncontrolled disease. J Allergy Clin Immunol (2007) 1.50
Timeliness across the continuum of care in veterans with lung cancer. J Thorac Oncol (2008) 1.49
An official American Thoracic Society systematic review: insurance status and disparities in lung cancer practices and outcomes. Am J Respir Crit Care Med (2010) 1.45
Evaluation of lifestyle interventions to treat elevated cardiometabolic risk in primary care (E-LITE): a randomized controlled trial. BMC Fam Pract (2009) 1.38
The pathogenetic and prognostic value of biologic markers in acute lung injury. J Intensive Care Med (2009) 1.36
Health-related quality of life in patients with pulmonary arterial hypertension. Chest (2004) 1.34
Identification of early acute lung injury at initial evaluation in an acute care setting prior to the onset of respiratory failure. Chest (2009) 1.28
Mediators of asthma outcomes. J Allergy Clin Immunol (2012) 1.21
Meta-analysis: accuracy of quantitative ultrasound for identifying patients with osteoporosis. Ann Intern Med (2006) 1.17
Management of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational Study. Chest (2015) 1.16
Tuberculosis in liver transplant recipients: a systematic review and meta-analysis of individual patient data. Liver Transpl (2009) 1.15
Idiopathic pulmonary fibrosis: challenges and opportunities for the clinician and investigator. Chest (2005) 1.14
Home-based asthma education of young low-income children and their families. J Pediatr Psychol (2002) 1.14
Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement. Chest (2015) 1.11
PET scan 18F-fluorodeoxyglucose uptake and prognosis in patients with resected clinical stage IA non-small cell lung cancer. Chest (2009) 1.07
Randomized trials and bronchoscopy. Chest (2013) 1.05
The Breathe Easier through Weight Loss Lifestyle (BE WELL) Intervention: a randomized controlled trial. BMC Pulm Med (2010) 1.00
Clinical practice. Lung-cancer screening with low-dose computed tomography. N Engl J Med (2014) 1.00
Risks of Transthoracic Needle Biopsy: How High? Clin Pulm Med (2013) 0.98
Development of the ATAQ-IPF: a tool to assess quality of life in IPF. Health Qual Life Outcomes (2010) 0.98
An Official American Thoracic Society/American College of Chest Physicians Policy Statement: Implementation of Low-Dose Computed Tomography Lung Cancer Screening Programs in Clinical Practice. Am J Respir Crit Care Med (2015) 0.96
Hospital characteristics associated with timeliness of care in veterans with lung cancer. Am J Respir Crit Care Med (2008) 0.96
Secondhand tobacco smoke in children with asthma: sources of and parental perceptions about exposure in children and parental readiness to change. Chest (2008) 0.96
Computed tomography screening for lung cancer. Ann Intern Med (2013) 0.96
Length of stay predictions: improvements through the use of automated laboratory and comorbidity variables. Med Care (2010) 0.96
Patient preference and contraindications in measuring quality of care: what do administrative data miss? J Clin Oncol (2013) 0.95
'The thing is not knowing': patients' perspectives on surveillance of an indeterminate pulmonary nodule. Health Expect (2012) 0.94
Evaluation of screening-detected lung nodules: minimising the risk of unnecessary biopsy and surgery. Thorax (2011) 0.91
An Official American Thoracic Society Research Statement: A Research Framework for Pulmonary Nodule Evaluation and Management. Am J Respir Crit Care Med (2015) 0.90
An official American thoracic society workshop report: developing performance measures from clinical practice guidelines. Ann Am Thorac Soc (2014) 0.90
The effect of an inhaled corticosteroid on glucose control in type 2 diabetes. Clin Med Res (2009) 0.88
DASH for asthma: a pilot study of the DASH diet in not-well-controlled adult asthma. Contemp Clin Trials (2013) 0.87
Variation in experts' beliefs about lung cancer growth, progression, and prognosis. J Thorac Oncol (2008) 0.85
Multidisciplinary management of lung cancer. N Engl J Med (2004) 0.85
Validity of standard gamble utilities as measured by transplant readiness in lung transplant candidates. Med Decis Making (2003) 0.85
A clinical prediction rule to estimate the probability of mediastinal metastasis in patients with non-small cell lung cancer. J Thorac Oncol (2006) 0.85
A home visiting asthma education program: challenges to program implementation. Health Educ Behav (2005) 0.83
Determinants of health utility in lung and heart-lung transplant recipients. Am J Transplant (2005) 0.82
Short-term weight loss patterns, baseline predictors, and longer-term follow-up within a randomized controlled trial. Obesity (Silver Spring) (2013) 0.82
Effectiveness and cost-effectiveness of thrombolysis in submassive pulmonary embolism. Arch Intern Med (2007) 0.82
Systematic reviews of observational studies of risk of thrombosis and bleeding in urological surgery (ROTBUS): introduction and methodology. Syst Rev (2014) 0.81
Shared clinician-patient decision-making about treatment of pediatric asthma: what do we know and how can we use it? Curr Opin Allergy Clin Immunol (2014) 0.81
Abdominal and general adiposity and level of asthma control in adults with uncontrolled asthma. Ann Am Thorac Soc (2014) 0.80
Delays in lung cancer care: time to improve. J Thorac Oncol (2009) 0.80
Variability in the use of thromboprophylaxis and outcomes in critically ill medical patients. Am J Med (2005) 0.80
The cost of positron emission tomography in six United States Veterans Affairs hospitals and two academic medical centers. AJR Am J Roentgenol (2003) 0.80
Lung cancer stage at diagnosis: Individual associations in the prospective VITamins and lifestyle (VITAL) cohort. BMC Cancer (2011) 0.79
Minimally invasive techniques for the diagnosis of peripheral pulmonary nodules. Curr Opin Pulm Med (2008) 0.79
The accuracy and trends of smoking history documentation in electronic medical records in a large managed care organization. Subst Use Misuse (2013) 0.79
Translating an evidence-based lifestyle intervention program into primary care: lessons learned. Health Promot Pract (2013) 0.79
Favorable stage distribution in the NELSON trial: promise or hype? Am J Respir Crit Care Med (2013) 0.78
Facility characteristics and quality of lung cancer care in an integrated health care system. J Thorac Oncol (2014) 0.78
Poor choice of primary outcome in a clinical trial of pirfenidone in patients with IPF. Am J Respir Crit Care Med (2005) 0.78
Low-value care for acute sinusitis encounters: who's choosing wisely? Am J Manag Care (2015) 0.77
CT screening for lung cancer. N Engl J Med (2007) 0.77
Influence of body mass index on effects of a shared asthma treatment decision-making intervention. Am J Respir Crit Care Med (2012) 0.76
Predicting in-hospital mortality among critically ill patients with end-stage liver disease. J Crit Care (2012) 0.76
The use and misuse of positron emission tomography in lung cancer evaluation. Clin Chest Med (2011) 0.76
Lung cancer screening debate. Chest (2003) 0.75
Lung cancer screening and elderly adults: do we have sufficient evidence? Ann Intern Med (2014) 0.75
Educational camp for children with asthma. J Bras Pneumol (2008) 0.75
Reply: Lung Cancer Screening: The Balance between Harm and Benefit. Am J Respir Crit Care Med (2015) 0.75
Adding measures to the asthma outcome measurement toolbox: new findings, new issues. J Allergy Clin Immunol (2012) 0.75